Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cochlear ( (AU:COH) ) just unveiled an update.
Cochlear Limited has applied for quotation of 236 ordinary fully paid shares on the Australian Securities Exchange. The new securities, issued on 30 April 2026 under an employee incentive scheme, are to be quoted and are not subject to transfer restrictions, reflecting routine equity issuance to staff rather than a sizeable capital raising or strategic shift.
The small scale of the issuance suggests minimal immediate impact on the company’s capital structure or market positioning. However, it underscores Cochlear’s ongoing use of equity-based incentives to align employee interests with shareholders and support long-term retention in a competitive medical technology sector.
The most recent analyst rating on (AU:COH) stock is a Hold with a A$111.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited is a medical device company specialising in implantable hearing solutions. Listed on the ASX under the code COH, it focuses on cochlear implants and related hearing technologies for patients with severe to profound hearing loss in global healthcare markets.
Average Trading Volume: 408,512
Technical Sentiment Signal: Sell
Current Market Cap: A$6.37B
For an in-depth examination of COH stock, go to TipRanks’ Overview page.